Supriya Lifescience standalone net profit rises 56.58% in the June 2024 quarter
Net profit of Supriya Lifescience rose 56.58% to Rs 44.64 crore in the quarter ended June 2024 as against Rs 28.51 crore during the previous quarter ended June 2023. Sales rose 21.67% to Rs 160.63 crore in the quarter ended June 2024 as against Rs 132.02 crore during the previous quarter ended June 2023.
| Particulars | Quarter Ended | ||
| Jun. 2024 | Jun. 2023 | % Var. | |
| Sales | 160.63 | 132.02 | 22 |
| OPM % | 38.94 | 33.50 | - |
| PBDT | 64.43 | 46.59 | 38 |
| PBT | 59.77 | 42.63 | 40 |
| NP | 44.64 | 28.51 | 57 |

Defrail Technologies IPO Allotment Status Online
5 mins read . Jan 21, 2026

Aritas Vinyl IPO Allotment Status Online
5 mins read . Jan 21, 2026

KRM Ayurveda IPO Allotment Status Online
5 mins read . Jan 20, 2026

Explore our products
Unlimited Trading starting at ₹249 ₹0
Open Trading Account